They found PK-DCE MRI to be superior in breast cancer diagnosis but less effective in predicting molecular subtypes, achieving AUCs of 0.71 ∼ 0.77 for predicting the Luminal subtype and 0.61 ∼ 0.68 for predicting the HER2-enriched subtype. The gene discussed is ERBB2; the disease is breast cancer.